Back180 Life Sciences - Warrants (07/11/2025) Overview

180 Life Sciences - Warrants (07/11/2025) Total Assets

180 Life Sciences - Warrants (07/11/2025)'s total assets is $160M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$159.03M
1384.31% YoYΔ $148.32M vs prior year quarter

Peer trimmed avg / median

Loading

180 Life Sciences - Warrants (07/11/2025) Total Assets History

Loading

180 Life Sciences - Warrants (07/11/2025) vs. peers: Total Assets Comparison

Loading

180 Life Sciences - Warrants (07/11/2025) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

180 Life Sciences - Warrants (07/11/2025) (ATNFW) FAQ

As of the most recent data (June 2026), ATNFW shows a total assets of $160M. That compares with $11M in the prior-year period — up 1384.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATNFW's total assets is now $160M (was $11M) — a 1384.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 180 Life Sciences - Warrants (07/11/2025) is outperforming or lagging.

Tracking ATNFW's total assets over time shows whether 180 Life Sciences - Warrants (07/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $11M in the prior-year period — up 1384.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has 180 Life Sciences - Warrants (07/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $160M) with ownership activity and broader fundamentals.

180 Life Sciences - Warrants (07/11/2025)'s total assets is $160M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.